Therapeutic and toxic activity of tumor necrosis factor is synergistic with gamma interferon.
Talmadge
J E
JE
Program Resources, Inc., NCI-Frederick Cancer Research Facility, Md.
Bowersox
O
O
Tribble
H
H
Shepard
M
M
Liggitt
D
D
D000818:Animals; D001241:Aspirin / Q000627:therapeutic use; D002478:Cells, Cultured; D003907:Dexamethasone / Q000627:therapeutic use; D004357:Drug Synergism; D007167:Immunotherapy; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D007371:Interferon-gamma / Q000494:pharmacology*; D008175:Lung Neoplasms / Q000628:therapy; D008546:Melanoma, Experimental / Q000628:therapy; D051379:Mice; D008810:Mice, Inbred C57BL; D011994:Recombinant Proteins / Q000494:pharmacology; D014409:Tumor Necrosis Factor-alpha / Q000627:therapeutic use*
D011994:Recombinant Proteins; D014409:Tumor Necrosis Factor-alpha; D003907:Dexamethasone; D007371:Interferon-gamma; D001241:Aspirin